You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 5, May 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Thoracic Surgery
 •Alert me on articles by topic

Persistent Acid and Bile Reflux in Asymptomatic Patients With Barrett Esophagus Receiving Proton Pump Inhibitor Therapy

Abeezar I. Sarela, MD; David G. Hick, PhD; Caroline S. Verbeke, MD; John F. Casey, PhD; Pierre J. Guillou, MD; Geoffrey W. B. Clark, MD

Arch Surg. 2004;139:547-551.

Hypothesis  Symptom control does not reflect elimination of abnormal acid reflux or abnormal bile reflux in patients with long-segment Barrett esophagus receiving proton pump inhibitors (PPIs).

Design  Prospective survey.

Setting  University hospital.

Patients  Thirty-two patients with long-segment Barrett esophagus who were asymptomatic with PPIs.

Main Outcome Measures  Twenty-four–hour ambulatory pH and bile reflux monitoring while continuing PPIs.

Results  Abnormal acid reflux (pH <4 for 11.9% [interquartile range, 6.8%-19.6%) of 24 hours] persisted in 15 patients (47%) who could not be distinguished from those with normal acid reflux (pH <4 for <4.5% of 24 hours) by any endoscopic, manometric, or therapeutic characteristic. Abnormal bile reflux (absorbance >0.14 for 8.7% [interquartile range, 3.9%-8.7%] of 24 hours) was detected in 11 (48%) of 23 patients, such that both normal bile reflux (absorbance >0.14 for <1.8% of 24 hours) and normal acid reflux were observed in only 8 patients (35%). There was no association between abnormal acid reflux and abnormal bile reflux.

Conclusions  Despite symptom control with PPIs, both acid reflux and bile reflux were controlled in only one third of patients. Posttherapeutic monitoring of acid and bile reflux is recommended in future clinical trials of PPI treatment vs laparoscopic antireflux surgery.


From the Academic Unit of Surgery, School of Medicine, University of Leeds (Drs Sarela, Guillou, and Clark), and the Departments of General Surgery (Drs Sarela, Guillou, and Clark) and Pathology (Dr Verbeke), and the Esophageal Laboratory (Drs Hick and Casey), St James's University Hospital, Leeds, England.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dilemmas in managing Barrett's oesophagus
DTB 2006;44:69-72.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.